Palvella Therapeutics annual revenue
2013
2014
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Palvella Therapeutics Revenue Growth & History (PVLA)
Palvella Therapeutics reported $0 in revenue for fiscal 2025.
View full Palvella Therapeutics company overviewPalvella Therapeutics annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $0 | $0 | — |
| 2024 | 2024-12-31 | $0 | −$38.7M | −100.00% |
| 2023 | 2023-12-31 | $38.7M | $13.2M | +51.99% |
| 2022 | 2022-12-31 | $25.5M | −$2.5M | −8.84% |
| 2021 | 2021-12-31 | $27.9M | $4.0M | +16.85% |
| 2020 | 2020-12-31 | $23.9M | −$19.7M | −45.22% |
| 2019 | 2019-12-31 | $43.6M | $16.4M | +60.18% |
| 2018 | 2018-12-31 | $27.2M | $2.0M | +7.81% |
| 2017 | 2017-12-31 | $25.3M | $19.4M | +333.46% |
| 2016 | 2016-12-31 | $5.8M | $2.9M | +98.88% |
| 2015 | 2015-12-31 | $2.9M | −$2.4M | −45.35% |
| 2014 · Dec 31 | 2014-12-31 | $5.4M | −$7.1M | −56.83% |
| 2014 · Jun 30 | 2014-06-30 | $0 | — | — |
| 2013 | 2013-12-31 | $12.4M | — | — |
Palvella Therapeutics quarterly revenue
Q3.13
Q4.13
Q1.14
Q4.14
Q1.15
Q4.14
Q1.15
Q2.15
Q3.15
Q4.15
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $0 | $0 | — |
| Q1 2026 | 2026-03-31 | $0 | — | — |
| Q4 2025 | 2025-12-31 | $0 | — | — |
| Q3 2025 | 2025-09-30 | $0 | $0 | — |
| Q2 2025 | 2025-06-30 | $0 | $0 | — |
| Q3 2024 | 2024-09-30 | $0 | −$15.6M | −100.00% |
| Q2 2024 | 2024-06-30 | $0 | −$20.1M | −100.00% |
| Q1 2024 | 2024-03-31 | $6,000 | −$2.0M | −99.70% |
| Q4 2023 | 2023-12-31 | $1.0M | −$4.7M | −81.68% |
| Q3 2023 | 2023-09-30 | $15.6M | $10.5M | +204.56% |
| Q2 2023 | 2023-06-30 | $20.1M | $16.6M | +479.18% |
| Q1 2023 | 2023-03-31 | $2.0M | −$9.2M | −82.02% |
| Q4 2022 | 2022-12-31 | $5.7M | −$2.0M | −26.34% |
| Q3 2022 | 2022-09-30 | $5.1M | $2.3M | +83.69% |
| Q2 2022 | 2022-06-30 | $3.5M | $928,000 | +36.54% |
| Q1 2022 | 2022-03-31 | $11.2M | −$3.7M | −24.79% |
| Q4 2021 | 2021-12-31 | $7.8M | $6.2M | +410.61% |
| Q3 2021 | 2021-09-30 | $2.8M | $205,000 | +7.95% |
| Q2 2021 | 2021-06-30 | $2.5M | −$8.4M | −76.76% |
| Q1 2021 | 2021-03-31 | $14.9M | $6.0M | +67.32% |
| Q4 2020 | 2020-12-31 | $1.5M | −$15.2M | −90.90% |
| Q3 2020 | 2020-09-30 | $2.6M | −$11.9M | −82.22% |
| Q2 2020 | 2020-06-30 | $10.9M | $6.0M | +121.52% |
| Q1 2020 | 2020-03-31 | $8.9M | $1.4M | +17.93% |
| Q4 2019 | 2019-12-31 | $16.7M | $12.0M | +254.37% |
| Q3 2019 | 2019-09-30 | $14.5M | $6.6M | +84.15% |
| Q2 2019 | 2019-06-30 | $4.9M | −$6.3M | −56.04% |
| Q1 2019 | 2019-03-31 | $7.5M | $4.1M | +118.76% |
| Q4 2018 | 2018-12-31 | $4.7M | −$13.4M | −74.07% |
| Q3 2018 | 2018-09-30 | $7.9M | $3.9M | +100.48% |
| Q2 2018 | 2018-06-30 | $11.2M | $9.4M | +505.72% |
| Q1 2018 | 2018-03-31 | $3.4M | $2.1M | +156.44% |
| Q4 2017 | 2017-12-31 | $18.2M | $15.4M | +565.77% |
| Q3 2017 | 2017-09-30 | $3.9M | $3.1M | +400.25% |
| Q2 2017 | 2017-06-30 | $1.9M | $780,138 | +72.72% |
| Q1 2017 | 2017-03-31 | $1.3M | $96,356 | +7.73% |
| Q4 2016 | 2016-12-31 | $2.7M | $587,031 | +27.44% |
| Q3 2016 | 2016-09-30 | $785,007 | $370,397 | +89.34% |
| Q2 2016 | 2016-06-30 | $1.1M | $912,618 | +569.52% |
| Q1 2016 | 2016-03-31 | $1.2M | $1.0M | +472.85% |
| Q4 2015 | 2015-12-31 | $2.1M | −$1.1M | −34.68% |
| Q3 2015 | 2015-09-30 | $414,610 | $395,886 | +2114.32% |
| Q2 2015 | 2015-06-30 | $160,244 | −$537,983 | −77.05% |
| Q1 2015 · Mar 31 | 2015-03-31 | $217,621 | −$1.2M | −84.15% |
| Q4 2014 | 2014-12-31 | $3.3M | $3.3M | — |
| Q1 2015 · Sep 30 | 2014-09-30 | $18,724 | $18,724 | — |
| Q4 2014 | 2014-06-30 | $698,227 | — | — |
| Q1 2014 | 2014-03-31 | $1.4M | — | — |
| Q4 2013 | 2013-12-31 | $0 | — | — |
| Q3 2013 | 2013-09-30 | $0 | — | — |
Palvella Therapeutics revenue growth trends
Palvella Therapeutics's latest reported quarter, Q2 2026, generated $0 in revenue.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review Palvella Therapeutics source filings ↗